MGE-22527-46517 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-26
Registered in v-safe
2022-08-17
Dose 1 — Pfizer-BioNTech
Co-administered: Do not remember
2022-09-27
Dose 2 — Pfizer-BioNTech
2022-11-06
Survey response — day 35, dose 2, under 3
MedDRA: Adenovirus infection, Croup infectious, Metapneumovirus infection — Feeling: Fair · Be unable to work or attend school

Free text: He has had adenovirus and hMPV, and croup.

MedDRA releases: 2024-11 · check-in free text available
2022-12-27
Survey response — 3 months, dose 2, under 3
MedDRA: Adenovirus infection, Croup infectious, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school

Free text: He got an adenovirus and croup. He did not test positive for Covid though.

MedDRA releases: 2024-11 · check-in free text available
2023-03-28
Health check-in — 6 months, dose 2, under 3
Feeling: Good

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-08-17	Pfizer-BioNTech	Do not remember
2	2022-09-27	Pfizer-BioNTech	No

Free text

Release 12 (Under 3) — day 35, dose 2, under 3

2022-11-06

Symptoms: He has had adenovirus and hMPV, and croup.

Release 12 (Under 3) — 3 months, dose 2, under 3

2022-12-27

Symptoms: He got an adenovirus and croup. He did not test positive for Covid though.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Adenovirus infection	·	·	✓
SD	Croup infectious	·	·	✓
SD	Metapneumovirus infection	·	·	✓
SD	SARS-CoV-2 test negative	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release